0001144204-17-026954.txt : 20170512
0001144204-17-026954.hdr.sgml : 20170512
20170512171935
ACCESSION NUMBER: 0001144204-17-026954
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20170511
FILED AS OF DATE: 20170512
DATE AS OF CHANGE: 20170512
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Moleculin Biotech, Inc.
CENTRAL INDEX KEY: 0001659617
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 474671999
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 2575 WEST BELLFORT
STREET 2: SUITE 333
CITY: HOUSTON
STATE: TX
ZIP: 77054
BUSINESS PHONE: 713-300-5160
MAIL ADDRESS:
STREET 1: 2575 WEST BELLFORT
STREET 2: SUITE 333
CITY: HOUSTON
STATE: TX
ZIP: 77054
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: KLEMP WALTER V
CENTRAL INDEX KEY: 0000938419
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37758
FILM NUMBER: 17839947
MAIL ADDRESS:
STREET 1: 1415 WEST LOOP NORTH
CITY: HOUSTON
STATE: TX
ZIP: 77055
4
1
v466826_form4.xml
FORMO 4
X0306
4
2017-05-11
0
0001659617
Moleculin Biotech, Inc.
MBRX
0000938419
KLEMP WALTER V
C/O MOLECULIN BIOTECH, INC.
2575 WEST BELLFORT, SUITE 333
HOUSTON
TX
77054
1
1
1
0
Chief Executive Officer
Common Stock
2017-05-11
4
P
0
12000
0.81
A
1067724
D
In addition to the shares held directly by the reporting person, the reporting person is the majority shareholder and control person of Annamed, Inc. Annamed, Inc. holds 1,425,000 shares of Issuer common stock. The Pursuant to General Instruction 5(b)(iv) of Form 3, the amount set forth in the table represents the reporting person's proportionate interest in the Issuer common stock beneficially owned by Annamed, Inc.
/s/ Walter Klemp
2017-05-11